Indeed, knocking Nrf2 out of mdx mice escalates DMD pathology when disease is aggravated by running (19), and applying Nrf2 activators sulforaphane (20) and curcumin (21) to the mdx mouse lessens myopathy. This evidence concerns the gene NFE2L2 and myopathy.